Compare MU & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MU | TMO |
|---|---|---|
| Founded | 1978 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.0B | 216.4B |
| IPO Year | N/A | N/A |
| Metric | MU | TMO |
|---|---|---|
| Price | $267.29 | $562.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 31 | 19 |
| Target Price | $275.90 | ★ $631.00 |
| AVG Volume (30 Days) | ★ 26.2M | 1.6M |
| Earning Date | 12-17-2025 | 01-29-2026 |
| Dividend Yield | 0.19% | ★ 0.31% |
| EPS Growth | ★ 204.55 | 8.54 |
| EPS | 10.54 | ★ 17.32 |
| Revenue | $42,312,000,000.00 | ★ $43,736,000,000.00 |
| Revenue This Year | $50.61 | $4.33 |
| Revenue Next Year | $16.26 | $4.94 |
| P/E Ratio | ★ $23.58 | $32.48 |
| Revenue Growth | ★ 45.43 | 3.22 |
| 52 Week Low | $61.54 | $385.46 |
| 52 Week High | $264.75 | $610.97 |
| Indicator | MU | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 44.17 |
| Support Level | $221.69 | $554.53 |
| Resistance Level | $264.75 | $579.08 |
| Average True Range (ATR) | 12.48 | 10.71 |
| MACD | 0.32 | -2.81 |
| Stochastic Oscillator | 96.54 | 25.10 |
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).